Form 8-K - Current report:
SEC Accession No. 0001658247-26-000003
Filing Date
2026-01-26
Accepted
2026-01-26 09:06:54
Documents
12
Period of Report
2026-01-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20260120.htm   iXBRL 8-K 25272
  Complete submission text file 0001658247-26-000003.txt   139411

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20260120.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20260120_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20260120_pre.xml EX-101.PRE 12512
14 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20260120_htm.xml XML 2725
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 26558630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)